期刊
CELLULAR AND MOLECULAR LIFE SCIENCES
卷 80, 期 1, 页码 -出版社
SPRINGER BASEL AG
DOI: 10.1007/s00018-022-04658-8
关键词
Liver; Fatty liver disease; Metabolomics; Free fatty acids; Bile acids; Uric acid; Hepatokines; Organokines; Metabolites; Interorgan crosstalk; NAFLD; NASH
Excessive fat accumulation in the liver is a major health threat globally, with unresolved deposition leading to various diseases. The interaction between metabolites released from the liver and other organs plays a crucial role in the development of fatty liver disease.
Excessive fat accumulation in the liver has become a major health threat worldwide. Unresolved fat deposition in the liver can go undetected until it develops into fatty liver disease, followed by steatohepatitis, fibrosis, cirrhosis, and eventually hepatocellular carcinoma. Lipid deposition in the liver is governed by complex communication, primarily between metabolic organs. This can be mediated by hormones, organokines, and also, as has been more recently discovered, metabolites. Although how metabolites from peripheral organs affect the liver is well documented, the effect of metabolic players released from the liver during the development of fatty liver disease or associated comorbidities needs further attention. Here we focus on interorgan crosstalk based on metabolites released from the liver and how these molecules act as signaling molecules in peripheral tissues. Due to the liver's specific role, we are covering lipid and bile mechanism-derived metabolites. We also discuss the high sucrose intake associated with uric acid release from the liver. Excessive fat deposition in the liver during fatty liver disease development reflects disrupted metabolic processes. As a response, the liver secretes a variety of signaling molecules as well as metabolites which act as a footprint of the metabolic disruption. In the coming years, the reciprocal exchange of metabolites between the liver and other metabolic organs will gain further importance and will help to better understand the development of fatty liver disease and associated diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据